H.C. Wainwright raised the firm’s price target on Scholar Rock (SRRK) to $65 from $58 and keeps a Buy rating on the shares. The regulatory and commercial updates reinforce confidence that the majority of Scholar Rock’s manufacturing setbacks have been resolved, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRRK:
- Scholar Rock reports Q1 EPS (83c), consensus (78c)
- Scholar Rock Advances Apitegromab Toward Potential 2026 Launches
- Scholar Rock initiated with a Buy at Canaccord
- Scholar Rock price target raised to $57 from $54 at Jefferies
- De-Risked Regulatory Path and Manufacturing Readiness Underpin Buy Rating on Apitegromab